Identification of host factors binding to dengue and Zika virus subgenomic RNA by efficient yeast three-hybrid screens of the human ORFeome.


Journal

RNA biology
ISSN: 1555-8584
Titre abrégé: RNA Biol
Pays: United States
ID NLM: 101235328

Informations de publication

Date de publication:
05 2021
Historique:
pubmed: 19 1 2021
medline: 15 12 2021
entrez: 18 1 2021
Statut: ppublish

Résumé

Flaviviruses such as the dengue (DENV) and the Zika virus (ZIKV) are important human pathogens causing around 100 million symptomatic infections each year. During infection, small subgenomic flavivirus RNAs (sfRNAs) are formed inside the infected host cell as a result of incomplete degradation of the viral RNA genome by cellular exoribonuclease XRN1. Although the full extent of sfRNA functions is to be revealed, these non-coding RNAs are key virulence factors and their detrimental effects on multiple cellular processes seem to consistently involve molecular interactions with RNA-binding proteins (RBPs). Discovery of such sfRNA-binding host-factors has followed established biochemical pull-down approaches skewed towards highly abundant proteins hampering proteome-wide coverage. Yeast three-hybrid (Y3H) systems represent an attractive alternative approach. To facilitate proteome-wide screens for RBP, we revisited and improved existing RNA-Y3H methodology by (1) implementing full-length ORF libraries in combination with (2) efficient yeast mating to increase screening depth and sensitivity, and (3) stringent negative controls to eliminate over-representation of non-specific RNA-binders. These improvements were validated employing the well-characterized interaction between DDX6 (DEAD-box helicase 6) and sfRNA of DENV as paradigm. Our advanced Y3H system was used to screen for human proteins binding to DENV and ZIKV sfRNA, resulting in a list of 69 putative sfRNA-binders, including several previously reported as well as numerous novel RBP host factors. Our methodology requiring no sophisticated infrastructure or analytic pipeline may be employed for the discovery of meaningful RNA-protein interactions at large scale in other fields.

Identifiants

pubmed: 33459164
doi: 10.1080/15476286.2020.1868754
pmc: PMC8086697
doi:

Substances chimiques

RNA, Viral 0
RNA-Binding Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

732-744

Références

Front Plant Sci. 2012 Aug 27;3:189
pubmed: 22969782
Methods Mol Biol. 2016;1358:153-73
pubmed: 26463383
Nat Methods. 2019 Mar;16(3):225-234
pubmed: 30804549
Wiley Interdiscip Rev RNA. 2019 Sep;10(5):e1536
pubmed: 31034160
Nat Methods. 2009 Jan;6(1):91-7
pubmed: 19060903
Nat Methods. 2018 Mar;15(3):207-212
pubmed: 29400715
Methods Mol Biol. 2014;1099:29-40
pubmed: 24243194
Cell Rep. 2016 Jun 28;16(1):232-246
pubmed: 27342126
Nat Commun. 2018 Jan 9;9(1):119
pubmed: 29317714
Nat Protoc. 2007;2(1):1-4
pubmed: 17401330
Science. 2015 Oct 9;350(6257):217-21
pubmed: 26138103
Methods. 2002 Feb;26(2):123-41
pubmed: 12054889
Science. 2004 Jan 23;303(5657):540-3
pubmed: 14704431
Mol Cell. 2016 Aug 18;63(4):696-710
pubmed: 27453046
Front Genet. 2015 Dec 17;6:346
pubmed: 26734059
J Virol. 2016 Oct 28;90(22):10145-10159
pubmed: 27581979
Genome Res. 2002 Dec;12(12):1935-42
pubmed: 12466298
Methods. 2012 Dec;58(4):367-75
pubmed: 22841566
mBio. 2017 Jul 18;8(4):
pubmed: 28720733
Methods Mol Biol. 2018;1794:207-224
pubmed: 29855959
Chem Rev. 2018 Apr 25;118(8):4448-4482
pubmed: 29652486
Proc Natl Acad Sci U S A. 2019 Sep 17;116(38):19136-19144
pubmed: 31488709
Genomics. 2007 Mar;89(3):307-15
pubmed: 17207965
Nat Methods. 2018 Sep;15(9):655-658
pubmed: 30171243
Nature. 2008 Sep 11;455(7210):242-5
pubmed: 18690214
Nucleic Acids Res. 2012 Jun;40(11):5065-77
pubmed: 22362731
Nucleic Acids Res. 2019 Jul 2;47(W1):W191-W198
pubmed: 31066453
Plant Cell. 2004 Apr;16(4):1047-59
pubmed: 15037734
Proc Natl Acad Sci U S A. 1999 Jun 8;96(12):6694-9
pubmed: 10359774
Cell. 2008 Aug 8;134(3):534-45
pubmed: 18692475
Curr Genet. 1989 Dec;16(5-6):339-46
pubmed: 2692852
PLoS Comput Biol. 2007 Nov;3(11):e214
pubmed: 18039026
Methods Mol Biol. 2015;1282:213-29
pubmed: 25720483
Elife. 2016 Mar 24;5:e11275
pubmed: 27011352
Nat Rev Cancer. 2018 Jan;18(1):5-18
pubmed: 29170536
Nucleic Acids Res. 2002 Dec 1;30(23):5017-28
pubmed: 12466525
Nat Commun. 2019 Aug 29;10(1):3907
pubmed: 31467278
Proc Natl Acad Sci U S A. 1996 Aug 6;93(16):8496-501
pubmed: 8710898
Nat Protoc. 2017 Dec;12(12):2447-2464
pubmed: 29095441
RNA Biol. 2011 Nov-Dec;8(6):1173-86
pubmed: 21957497
Science. 1999 Aug 6;285(5429):901-6
pubmed: 10436161
Science. 2014 Apr 18;344(6181):307-10
pubmed: 24744377
PLoS Genet. 2013 Mar;9(3):e1003374
pubmed: 23555288
Virol J. 2016 May 28;13:84
pubmed: 27233361
Nat Commun. 2018 Sep 14;9(1):3747
pubmed: 30217970
J Proteome Res. 2020 Jul 2;19(7):2529-2538
pubmed: 32216351
Nucleic Acids Res. 2018 Jan 25;46(2):e12
pubmed: 29140461
Nature. 2013 Jul 4;499(7456):79-82
pubmed: 23676674
Curr Alzheimer Res. 2016;13(11):1219-1231
pubmed: 27338628
J Virol. 2012 Mar;86(6):3121-34
pubmed: 22258240
J Biol Chem. 2019 Nov 1;294(44):16282-16296
pubmed: 31519749
Nat Rev Mol Cell Biol. 2018 May;19(5):327-341
pubmed: 29339797
RNA. 2012 Nov;18(11):2029-40
pubmed: 23006624
Nucleic Acids Res. 2004 Feb 18;32(3):e37
pubmed: 14973331
Cell Host Microbe. 2015 Aug 12;18(2):133-4
pubmed: 26269946
Cell Host Microbe. 2008 Dec 11;4(6):579-91
pubmed: 19064258
RNA. 2005 Feb;11(2):227-33
pubmed: 15613539
Nucleic Acids Res. 1996 Dec 1;24(23):4838-40
pubmed: 8972875

Auteurs

Sander Jansen (S)

KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory of Virology and Chemotherapy, Leuven, Belgium.

Enisa Smlatic (E)

KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory of Virology and Chemotherapy, Leuven, Belgium.
Division of Paediatric Infectious Diseases, Ludwig-Maximilians-University Munich, Dr. Von Hauner Children's Hospital, Munich, Germany.

Daniëlle Copmans (D)

KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory of Virology and Chemotherapy, Leuven, Belgium.
KU Leuven Department of Pharmaceutical and Pharmacological Sciences, Laboratory for Molecular Biodiscovery, Leuven, Belgium.

Sarah Debaveye (S)

KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory of Virology and Chemotherapy, Leuven, Belgium.

Frédéric Tangy (F)

Unité de Génomique Virale et Vaccination, Institut Pasteur, CNRS, Paris, France.

Pierre-Olivier Vidalain (PO)

Unité de Génomique Virale et Vaccination, Institut Pasteur, CNRS, Paris, France.
CIRI, Centre International de Recherche en Infectiologie, Univ Lyon, Inserm U1111, Université Claude Bernard Lyon 1, Lyon, France.

Johan Neyts (J)

KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory of Virology and Chemotherapy, Leuven, Belgium.

Kai Dallmeier (K)

KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory of Virology and Chemotherapy, Leuven, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH